Eurofarma Biosimilars Deal Broadens Access To Latin America For Henlius

Chinese Firm’s Bevacizumab, Rituximab And Trastuzumab Included In $50m Deal

 
• By Dave Wallace
  
Latin America globe from space
Henlius will broaden access to markets in Latin America through the alliance with Brazil’s Eurofarma • Source: Shutterstock

More from Deals

More from Business